Ceeto Capital Group’s Eli Lilly LLY Stock Holding History

Ceeto Capital Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.79M	Buy	3,030 +300	+11%	+$304K	0.86%	28
2025 Q4	$2.93M	Hold	2,730	–	–	0.86%	25
2025 Q3	$2.08M	Buy	2,730 +1,000	+58%	+$744K	0.6%	34
2025 Q2	$1.35M	Buy	1,730 +100	+6%	+$77.7K	0.47%	53
2025 Q1	$1.35M	Hold	1,630	–	–	0.51%	43
2024 Q4	$1.26M	Hold	1,630	–	–	0.46%	44
2024 Q3	$1.44M	Sell	1,630 -1,000	-38%	-$899K	0.54%	40
2024 Q2	$2.38M	Buy	2,630 +500	+23%	+$400K	0.92%	19
2024 Q1	$1.66M	Buy	2,130 +100	+5%	+$71.2K	0.68%	39
2023 Q4	$1.18M	Hold	2,030	–	–	0.51%	47
2023 Q3	$1.09M	Hold	2,030	–	–	0.53%	46
2023 Q2	$952K	Hold	2,030	–	–	0.44%	52
2023 Q1	$697K	Hold	2,030	–	–	0.35%	63
2022 Q4	$743K	Buy	2,030 +1,030	+103%	+$365K	0.41%	60
2022 Q3	$323K	Hold	1,000	–	–	0.19%	113
2022 Q2	$324K	Buy	+1,000	New	+$300K	0.18%	112

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Ceeto Capital Group's LLY Position: Q1 2026 in Review

Ceeto Capital Group increased its Eli Lilly (LLY) stake by 11% in Q1 2026, buying an estimated $304K and bringing the position to 3,030 shares worth $2.79M. The position accounts for 0.86% of the portfolio, ranked #28.

Ceeto Capital Group first reported a position in LLY in Q2 2022 and has held it in 16 quarters since. The position peaked at $2.93M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Ceeto Capital Group held 3,030 shares of Eli Lilly worth $2.79M as of Q1 2026.
Ceeto Capital Group bought 300 Eli Lilly shares in Q1 2026, an estimated $304K.
Eli Lilly made up 0.86% of Ceeto Capital Group's portfolio in Q1 2026, its #28 holding.
Ceeto Capital Group first reported a position in Eli Lilly in Q2 2022 and has held it in 16 quarters since.
Ceeto Capital Group's Eli Lilly position peaked at $2.93M in Q4 2025.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Ceeto Capital Group's 13F filing for Q1 2026, filed 14 May 2026.